Brain zaps and booze: new study probes TMS effects on alcohol addiction
NCT ID NCT06770556
First seen Jun 27, 2026 · Last updated Aug 18, 2026 · Updated 2 times
Summary
This study explores how transcranial magnetic stimulation (TMS) changes brain activity in people with and without heavy alcohol use. Researchers will use magnetoencephalography (MEG) to measure brain signals before and after TMS. The goal is to gather early data to support future research on TMS as a potential treatment for alcohol use disorder. Ten adults will participate.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
5 people
The number who actually took part.
- Started
-
Mar 2025
- Finished
-
Jul 2026
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
21 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria non-AUD Participants: * Diagnostic and Statistical Manual of Mental Disorders (DSM-5) score for AUD = 0 * Alcohol Use Disorders Identification Test (AUDIT) score ≤ 7 * Is not a heavy alcohol consumer Inclusion Criteria AUD Participants: * DSM-5 score for AUD ≥ 3 * AUDIT score ≥ 8 * Is a heavy alcohol consumer Exclusion Criteria: * Current substance use disorder other than alcohol use disorder and/or frequent use of non-prescribed psychoactive substances. * Current serious psychiatric disorder, and/or any history of a psychotic disorder * Any health problem that would interfere with the study or could be aggravated by study procedures (e.g., history of migraines, claustrophobia). * Is currently taking or initiates a medication known to affect alcohol intake and/or craving. * History of traumatic brain injury resulting in hospitalization, loss of consciousness, and/or having ever been informed he/she has an epidural, subdural, or subarachnoid hemorrhage. * Does not meet safety criteria for TMS or MRI. * Females of childbearing potential who are pregnant (by urine HCG), planning to become pregnant, nursing, or who are not using a reliable form of birth control. * Is at an elevated risk of seizure (i.e. has a history of seizures, is currently prescribed medications known to lower seizure threshold and has had a change in their medication). * Clinical Intake Withdrawal Assessment (CIWA\>5) (to prevent delivering TMS to individuals in withdrawal). * Not able to read and understand questionnaires, assessments, and/or the informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Alcohol consumption are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Wake Forest University Health Sciences
Winston-Salem, North Carolina, 27157, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Brain-Training games rewire the mind to fight alcohol addiction?
- Can a Stress-Hormone blocker take the edge off alcohol?
- Can MDMA plus therapy help veterans fight both PTSD and alcohol addiction?
- Brain scans probe opioid receptor imbalance in alcohol use disorder
- Spinal taps open a window on alcohol use disorder
- Can a natural alcohol byproduct calm withdrawal? hospital trial tests IV acetate